Value of ECT in the diagnosis of osseous metastases in prostate cancer

被引:0
|
作者
Chen, Hai-Jiao [1 ]
Shao, Zhen-Hua [2 ]
Zhang, Li [1 ]
Ye, Chuan-Zhong [1 ]
Zhang, Yong-Kang [1 ]
机构
[1] Department of Urology, Zhongshan Hospital, Fudan University, Shanghai 200032, China
[2] Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China
来源
关键词
Computerized tomography - Magnetic resonance imaging - Tumors;
D O I
暂无
中图分类号
学科分类号
摘要
Purpose: To evaluate the value of ECT in the diagnosis of osseous metastases in prostate cancer. Methods: From July 1996 to January 2001, fifty-eight cases of prostate cancer with osseous metastases by ECT,CT,MRI, X-ray were reviewed. Imaging findings were measured and analyzed. Results: The accuracy of ECT, CT, MRI and X-ray was 100%, 35%, 42% and 29% respectively. Conclusions: ECT has important value in early diagnosis of osseous metastases in prostate cancer.
引用
收藏
页码:80 / 81
相关论文
共 50 条
  • [31] Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases
    Holger Palmedo
    Stefan Guhlke
    Hans Bender
    Johannes Sartor
    Georg Schoeneich
    Jörn Risse
    Frank Grünwald
    F.F. [Russ] Knapp Jr.
    Hans-Jürgen Biersack
    European Journal of Nuclear Medicine, 2000, 27 : 123 - 130
  • [32] Dose escalation study with Re-188HEDP in prostate cancer patients with osseous metastases.
    Palmedo, H
    Guhlke, S
    Bender, H
    Sartor, J
    Schoeneich, G
    Risse, J
    Gruenwald, F
    Knapp, FF
    Biersack, HJ
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 218P - 218P
  • [33] Predictive value of standard serum markers for bone metastases in prostate cancer
    Ozdemir, Semra
    Ersay, Ahmet Resit
    Ozturk, Fulya Koc
    Ozdemir, Beril Su
    AFRICAN JOURNAL OF UROLOGY, 2021, 27 (01)
  • [34] Predictive value of standard serum markers for bone metastases in prostate cancer
    Semra Ozdemir
    Ahmet Reşit Ersay
    Fulya Koc Ozturk
    Beril Su Ozdemir
    African Journal of Urology, 2021, 27
  • [35] CANCER OF PROSTATE WITH OSSEOUS METASTASES - PROLONGED PAIN RELIEF WITH VERY HIGH-DOSE EPIDURAL MORPHINE
    STAV, A
    OVADIA, L
    LANDAU, M
    WEKSLER, N
    STERNBERG, A
    WORLD JOURNAL OF UROLOGY, 1991, 9 (04) : 240 - 242
  • [36] Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases
    Palmedo, H
    Guhlke, S
    Bender, H
    Sartor, J
    Schoeneich, G
    Risse, J
    Grünwald, F
    Knapp, FF
    Biersack, HJ
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (02) : 123 - 130
  • [37] Metastases in Prostate Cancer
    La Manna, Federico
    Karkampouna, Sofia
    Zoni, Eugenio
    De Menna, Marta
    Hensel, Janine
    Thalmann, George N.
    Kruithof-de Julio, Marianna
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2019, 9 (03):
  • [38] Risk factors of developing visceral metastases at diagnosis in prostate cancer patients
    Xu, Ning
    Wu, Yu-Peng
    Ke, Zhi-Bin
    Liang, Ying-Chun
    Tao, Xuan
    Chen, Shao-Hao
    Li, Xiao-Dong
    Cai, Hai
    Lin, Yun-Zhi
    Lin, Ting-Ting
    Xue, Xue-Yi
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (03) : 928 - 938
  • [39] Risk factors of developing visceral metastases at diagnosis in prostate cancer patients
    Xu, N.
    Wu, Y. -P.
    Ke, Z. -B.
    Liang, Y. -C.
    Tao, X.
    Chen, S. -H.
    Li, X. -D.
    Cai, H.
    Lin, Y. -Z.
    Lin, T. -T.
    Xue, X. -Y.
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 182 - 182
  • [40] The value of serum prostate specific antigen and other parameters in detecting bone metastases in prostate cancer
    Ataus S.
    Çitçi A.
    Alici B.
    Önder A.U.
    Sönmezoǧlu K.
    Erözenci A.
    Solok V.
    International Urology and Nephrology, 1999, 31 (4) : 481 - 489